Cargando…
Development and Scalable Production of Newcastle Disease Virus-Vectored Vaccines for Human and Veterinary Use
The COVID-19 pandemic has highlighted the need for efficient vaccine platforms that can rapidly be developed and manufactured on a large scale to immunize the population against emerging viruses. Viral-vectored vaccines are prominent vaccine platforms that have been approved for use against the Ebol...
Autores principales: | Fulber, Julia P. C., Kamen, Amine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143368/ https://www.ncbi.nlm.nih.gov/pubmed/35632717 http://dx.doi.org/10.3390/v14050975 |
Ejemplares similares
-
Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension Cultures
por: Fulber, Julia Puppin Chaves, et al.
Publicado: (2021) -
Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2016) -
Establishing a Robust Manufacturing Platform for Recombinant Veterinary Vaccines: An Adenovirus-Vector Vaccine to Control Newcastle Disease Virus Infections of Poultry in Sub-Saharan Africa
por: Farnós, Omar, et al.
Publicado: (2020) -
Development of an Integrated Continuous Manufacturing Process for the rVSV-Vectored SARS-CoV-2 Candidate Vaccine
por: Yang, Zeyu, et al.
Publicado: (2023) -
Vero cell upstream bioprocess development for the production of viral vectors and vaccines
por: Kiesslich, Sascha, et al.
Publicado: (2020)